GSK Pays $2.6M To Exit Idaho Drug Price-Fixing Suit
GlaxoSmithKline PLC on Tuesday agreed to pay $2.6 million to resolve Idaho's claims that the drug giant sold its products at inflated prices, the 14th settlement the state has reached with...To view the full article, register now.
Already a subscriber? Click here to view full article